These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12611274)

  • 41. D-Phe-Pro-Arg type thrombin inhibitors: unexpected selectivity by modification of the P1 moiety.
    Lange UE; Baucke D; Hornberger W; Mack H; Seitz W; Höffken HW
    Bioorg Med Chem Lett; 2003 Jun; 13(12):2029-33. PubMed ID: 12781189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Synthetic inhibitors of serine proteinases. 12. The inhibition of trypsin, plasmin and thrombin by 3-[amidinophenyl]-1-phenyl-propanone-(1) with substituents in the aliphatic intermediate chain].
    Walsmann P; Griessmann R; Horn H; Markwardt F; Richter P; Stürzebecher J; Wagner G
    Pharmazie; 1976 Jun; 31(6):410-1. PubMed ID: 134380
    [No Abstract]   [Full Text] [Related]  

  • 43. Design of weakly basic thrombin inhibitors incorporating novel P1 binding functions: molecular and X-ray crystallographic studies.
    De Simone G; Menchise V; Omaggio S; Pedone C; Scozzafava A; Supuran CT
    Biochemistry; 2003 Aug; 42(30):9013-21. PubMed ID: 12885234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s.
    Subasinghe NL; Travins JM; Ali F; Huang H; Ballentine SK; Marugán JJ; Khalil E; Hufnagel HR; Bone RF; DesJarlais RL; Crysler CS; Ninan N; Cummings MD; Molloy CJ; Tomczuk BE
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2200-4. PubMed ID: 16460935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure-activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors.
    Chou YL; Davey DD; Eagen KA; Griedel BD; Karanjawala R; Phillips GB; Sacchi KL; Shaw KJ; Wu SC; Lentz D; Liang AM; Trinh L; Morrissey MM; Kochanny MJ
    Bioorg Med Chem Lett; 2003 Feb; 13(3):507-11. PubMed ID: 12565961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. From natural products to achiral drug prototypes: potent thrombin inhibitors based on P2/P3 dihydropyrid-2-one core motifs.
    Hanessian S; Therrien E; Zhang J; Otterlo Wv; Xue Y; Gustafsson D; Nilsson I; Fjellström O
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5429-32. PubMed ID: 19674897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and Evaluation of Spumigin Analogues Library with Thrombin Inhibitory Activity.
    Žula A; Będziak I; Kikelj D; Ilaš J
    Mar Drugs; 2018 Oct; 16(11):. PubMed ID: 30373260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of thrombin and other trypsin-like serine proteinases by cyclotheonamide A.
    Lewis SD; Ng AS; Baldwin JJ; Fusetani N; Naylor AM; Shafer JA
    Thromb Res; 1993 Apr; 70(2):173-90. PubMed ID: 8322286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis of potential thrombin inhibitors. Incorporation of tartaric acid templates as P2 proline mimetics.
    Dahlgren A; Brånalt J; Kvarnström I; Nilsson I; Musil D; Samuelsson B
    Bioorg Med Chem; 2002 May; 10(5):1567-80. PubMed ID: 11886818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumonoic acids, novel metabolites from a cyanobacterial assemblage of Lyngbya majuscula and Schizothrix calcicola.
    Harrigan GG; Luesch H; Yoshida WY; Moore RE; Nagle DG; Biggs J; Park PU; Paul VJ
    J Nat Prod; 1999 Mar; 62(3):464-7. PubMed ID: 10096859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.
    Parlow JJ; Case BL; Dice TA; Fenton RL; Hayes MJ; Jones DE; Neumann WL; Wood RS; Lachance RM; Girard TJ; Nicholson NS; Clare M; Stegeman RA; Stevens AM; Stallings WC; Kurumbail RG; South MS
    J Med Chem; 2003 Sep; 46(19):4050-62. PubMed ID: 12954058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants.
    Lin J; Deng H; Jin L; Pandey P; Quinn J; Cantin S; Rynkiewicz MJ; Gorga JC; Bibbins F; Celatka CA; Nagafuji P; Bannister TD; Meyers HV; Babine RE; Hayward NJ; Weaver D; Benjamin H; Stassen F; Abdel-Meguid SS; Strickler JE
    J Med Chem; 2006 Dec; 49(26):7781-91. PubMed ID: 17181160
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lyngbyastatins 5-7, potent elastase inhibitors from Floridian marine cyanobacteria, Lyngbya spp.
    Taori K; Matthew S; Rocca JR; Paul VJ; Luesch H
    J Nat Prod; 2007 Oct; 70(10):1593-600. PubMed ID: 17910513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure/function aspects of neutral P1 residue peptide inhibitors of thrombin.
    Deadman J; Claeson G; Scully MF
    J Enzyme Inhib; 1995; 9(1):29-41. PubMed ID: 8568564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 4-Heterocyclohexanone-based inhibitors of the serine protease plasmin.
    Sanders TC; Seto CT
    J Med Chem; 1999 Jul; 42(15):2969-76. PubMed ID: 10425106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Synthetic inhibitors of serine proteinases. Part 24: Inhibition of trypsin, plasmin and thrombin by cyclic amides of N alpha-arylsulfonylamidinophenyl-glycines (author's transl)].
    Stürzebecher J; Markwardt F; Voigt B; Wagner G; Walsmann P
    Pharmazie; 1981; 36(7):501-2. PubMed ID: 6456466
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and in vitro biological evaluation of aryl boronic acids as potential inhibitors of factor XIa.
    Lazarova TI; Jin L; Rynkiewicz M; Gorga JC; Bibbins F; Meyers HV; Babine R; Strickler J
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5022-7. PubMed ID: 16876411
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective inhibitors of the serine protease plasmin: probing the S3 and S3' subsites using a combinatorial library.
    Xue F; Seto CT
    J Med Chem; 2005 Nov; 48(22):6908-17. PubMed ID: 16250649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Synthetic serine proteinase inhibitors. 30. Synthesis of alpha-benzoylamino-4-amidinocinnamic acid and alpha-(4-amidinobenzoylamino) cinnamic acid amides, and their inhibitory effect on trypsin-like enzymes].
    Voigt B; Wagner G; Walsmann P; Stürzebecher J; Markwardt F
    Pharmazie; 1983 Dec; 38(12):835-8. PubMed ID: 6230681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peptidyl vinyl ester derivatives: new class of selective inhibitors of proteasome trypsin-like activity.
    Marastoni M; Baldisserotto A; Cellini S; Gavioli R; Tomatis R
    J Med Chem; 2005 Jul; 48(15):5038-42. PubMed ID: 16033282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.